| Phase 03 trials |
|
Phase 0
|
NCT07435779 |
Feb 2026 → Feb 2027 expected |
— |
Hebei Senlang Biotechnology Inc., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 0
|
NCT06681337 |
Nov 2024 → Dec 2025 overdue |
lupus nephritis |
Bioray Laboratories |
Not yet recruiting
|
No outcome recorded
|
|
Phase 0
|
NCT04626752 |
Apr 2020 → Mar 2023 |
refractory plasma cell neoplasm |
Hebei Senlang Biotechnology Inc., Ltd. |
Unknown
|
No outcome recorded
|
| Phase 1/22 trials |
|
Phase 1/2
|
NCT07109323 |
Mar 2025 → Mar 2028 expected |
extramedullary soft tissue plasmacytoma, plasma cell leukemia, refractory plasma cell neoplasm |
Institute of Hematology & Blood Diseases Hospital, China |
Recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT03322735 |
Dec 2017 → Oct 2018 |
plasma cell myeloma |
Henan Cancer Hospital |
Unknown
|
No outcome recorded
|
| Phase 24 trials |
|
Phase 2
|
NCT07106684 |
Aug 2025 → Aug 2027 expected |
plasma cell leukemia |
Institute of Hematology & Blood Diseases Hospital, China |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07106736 |
Aug 2025 → Aug 2027 expected |
plasma cell myeloma |
Institute of Hematology & Blood Diseases Hospital, China |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07106710 |
Aug 2025 → Aug 2027 expected |
plasma cell myeloma |
Institute of Hematology & Blood Diseases Hospital, China |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06581640 |
Sep 2024 → Dec 2028 expected |
plasma cell myeloma, refractory plasma cell neoplasm |
The First Affiliated Hospital of Xiamen University |
Recruiting
|
No outcome recorded
|
| Phase not applicable4 trials |
| — |
NCT05618041 |
Sep 2022 → Sep 2027 expected |
acute lymphoblastic leukemia, plasma cell myeloma |
Hebei Senlang Biotechnology Inc., Ltd. |
Recruiting
|
No outcome recorded
|
| — |
NCT03492268 |
Nov 2021 → Dec 2022 |
plasma cell myeloma |
Bioray Laboratories |
Withdrawn
|
No outcome recorded
|
| — |
NCT04447573 |
Jun 2020 → Aug 2022 |
plasma cell myeloma |
Hebei Senlang Biotechnology Inc., Ltd. |
Unknown
|
No outcome recorded
|
| — |
NCT03473496 |
Mar 2018 → Jan 2020 |
plasma cell myeloma |
Zhujiang Hospital |
Terminated
|
No outcome recorded
Stop: Enrollment |